Zura Bio Limited (ZURA)
NASDAQ: ZURA · Real-Time Price · USD
1.880
+0.120 (6.82%)
Jan 31, 2025, 4:00 PM EST - Market closed
Zura Bio Employees
As of December 31, 2023, Zura Bio had 15 total employees, including 14 full-time and 1 part-time employees.
Employees
15
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
-$2,841,067
Market Cap
122.75M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 15 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher Scientific | 122,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 89,900 |
| Novartis AG | 75,883 |
| Merck & Co. | 72,000 |
| Novo Nordisk | 64,319 |
ZURA News
- 5 weeks ago - Zura Bio Launches Global Phase 2 TibuSURE Study to Evaluate Tibulizumab in Adults With Systemic Sclerosis - Business Wire
- 2 months ago - Zura Bio to Present at the Piper Sandler 36th Annual Healthcare Conference - Business Wire
- 2 months ago - Zura Bio Announces Submission of Protocol to U.S. Food and Drug Administration for the Phase 2 Study of Tibulizumab in Adults with Systemic Sclerosis - Business Wire
- 3 months ago - Zura Bio Reports Third Quarter 2024 Financial Results and Recent Corporate Updates - Business Wire
- 3 months ago - Zura Bio to Participate in Two Upcoming Investor Conferences in November - Business Wire
- 5 months ago - CPS HR Consulting Partners with GovInvest to Revolutionize Compensation Consulting with Advanced Technology - Business Wire
- 5 months ago - Zura Bio to Present at Three Upcoming Investor Conferences in September - Business Wire
- 6 months ago - Zura Bio Reports Second Quarter 2024 Financial Results and Recent Business Highlights - Business Wire